After steller IPOs, market corrections drove down valuations of new-age companies. What led to this divergence? What does changes in lock-in period for anchor investors in an IPO mean? Let's find out
The tax rate for business income is 42.7 per cent after surcharge and cess
Anti-covid drug approval, new facility are the near term triggers for the pharma firm's stock
Energy conglomerate looking for strategic investors; plans to list subsidiary
Going forward, analysts said investors should be cautious due to Omicron and interest-rate concerns
Covid-19 has accelerated the growth of IT companies with rise in demand for digitisation
With China being a problem child for foreign investors, India has made a killing with new issuances
While the retail holding in NSE listed companies had risen between December 2019 and September this year, their holding in equity mutual funds had seen a decline, the report observed.
From equities to commodities and cryptocurrencies, most segments gave handsome returns. But inflation, rate tightening, and the Omicron spread have spoiled the year-end party
The Delhi Disaster Management Authority, on Tuesday, ordered the closure of schools, colleges, cinemas and gyms with immediate effect
The relative outperformance of midcap stocks is in mid-cycle of multi year bull phase, and is expected to get further amplified
The industry closed the first six months of the current fiscal with asset growth of only five per cent, rating agency ICRA NSE 0.06 % said in the report released on Wednesday.
The BSE Midcap and the Smallcap indices were up 0.1 per cent and 0.5 per cent, respectively. The overall breadth also was fairly positive, with 2,043 advanced shares v/s 1,334 declining stocks.
Shares of Digjam were locked in the upper circuit for the eighth straight trading day, up 5 per cent at Rs 224.50.
Vodafone Idea can jump up to 40% from current levels, while Bharti Airtel may see a 6 per cent rise.
Supriya Lifescience has a niche product portfolio of 38 APIs with focus primarily on diverse therapeutic areas.
Stock market minnows put up a stellar show in 2021 giving returns of up to 60 per cent amid Dalal Street dream run and are likely to continue sailing northwards in the New Year too.
The stock of ASM Technologies was locked in the upper circuit for the 12th straight day, up 5 per cent at Rs 687.50, quoting at an all-time high level on the BSE
Major textile stocks are witnessing sideways to breakout formations, this may see stronger interest of market participants.
Sun Pharma, Cipla, Natco, Dr Reddy's, Torrent Pharma, Aurobindo Pharma and Strides have launched a generic version of Molnupiravir in India post approval for emergency use authorisation from DCGI